StonvexLoading…
StonvexStonvexStonvexCore line items from CHCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $62.86M | $51.29M | $44.72M | $39.31M |
Operating Income | $11.93M | $10.29M | $9.16M | $7.95M |
Net Income | $17.05M | $14.56M | $7.78M | $7.35M |
EPS (Diluted) | $1.63 | $1.41 | $0.77 | $0.98 |
Total Assets | $84.96M | $64.87M | $49.94M | $42.47M |
Total Liabilities | $15.00M | $12.50M | $12.72M | $13.62M |
Cash & Equivalents | $31.28M | $28.76M | $18.79M | $11.72M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 10.47M | 10.33M | 10.11M | 9.57M |